Ali Raza

1.1k total citations
30 papers, 812 citations indexed

About

Ali Raza is a scholar working on Surgery, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ali Raza has authored 30 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 5 papers in Epidemiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ali Raza's work include Lipoproteins and Cardiovascular Health (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Ali Raza is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Ali Raza collaborates with scholars based in United States, Pakistan and United Kingdom. Ali Raza's co-authors include Anders Olsson, Fergus McTaggart, Aaron Dane, John Pears, John McKellar, Mike J. Warwick, Dennis W. Schneck, Paul Martin, Evan A. Stein and Rohini Chitra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Ali Raza

23 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Raza United States 10 553 255 163 151 103 30 812
John Pears United Kingdom 12 645 1.2× 309 1.2× 273 1.7× 193 1.3× 35 0.3× 22 976
Mike J. Warwick United Kingdom 12 485 0.9× 213 0.8× 105 0.6× 125 0.8× 247 2.4× 14 873
Aditi Sapre United States 13 882 1.6× 191 0.7× 420 2.6× 274 1.8× 97 0.9× 23 1.2k
Meehyung Cho United States 9 573 1.0× 199 0.8× 238 1.5× 202 1.3× 49 0.5× 14 807
Bruce K. Birmingham United States 13 406 0.7× 122 0.5× 132 0.8× 108 0.7× 258 2.5× 23 933
Julie Zalikowski United States 6 287 0.5× 100 0.4× 82 0.5× 77 0.5× 169 1.6× 7 516
J.W. Nawrocki United States 5 439 0.8× 187 0.7× 152 0.9× 63 0.4× 38 0.4× 13 622
André Árpád Faludi Brazil 16 355 0.6× 64 0.3× 233 1.4× 101 0.7× 92 0.9× 42 991
Donald D. Cilla United States 8 332 0.6× 78 0.3× 183 1.1× 104 0.7× 37 0.4× 12 593
James C. Stolzenbach United States 16 465 0.8× 82 0.3× 366 2.2× 144 1.0× 38 0.4× 35 686

Countries citing papers authored by Ali Raza

Since Specialization
Citations

This map shows the geographic impact of Ali Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Raza more than expected).

Fields of papers citing papers by Ali Raza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Raza. The network helps show where Ali Raza may publish in the future.

Co-authorship network of co-authors of Ali Raza

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Raza. A scholar is included among the top collaborators of Ali Raza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Raza. Ali Raza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saleem, Zikria, Muhammad Usman Qamar, Ali Raza, et al.. (2025). Identifying targets for antibiotic stewardship interventions in pediatric patients in Punjab, Pakistan: point prevalence surveys using AWaRe guidance. Frontiers in Pediatrics. 12. 1469766–1469766. 3 indexed citations
2.
Raza, Ali, M Goulet, Huaqing Zhao, et al.. (2025). Clinical Utility of Plasma Donor-Derived Cell-Free DNA for Detection of Lung Allograft Rejection in Patients With Lung Transplant: Experience from a Large Lung Transplant Program. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1132–A1132.
3.
Zeeshan, A., et al.. (2025). Designing Nanoparticle-Driven Materials for High-Performance Applications a Multidisciplinary Review. 13(1). 148–158. 1 indexed citations
4.
Raza, Ali, et al.. (2025). Revolutionizing pharmacology: AI-powered approaches in molecular modeling and ADMET prediction. SHILAP Revista de lepidopterología. 28. 100223–100223. 4 indexed citations
5.
Saqib, Muhammad Arif Nadeem, Ibrar Rafique, Obaid Ullah, et al.. (2020). Protection against Haemophilus influenzae Type B, Diphtheria, and Tetanus in Children from Major Cities of Pakistan: A Community-Based Study. Journal of Pediatric Infectious Diseases. 15(4). 163–168.
6.
Thosani, Nirav, Neil Sharma, Isaac Raijman, et al.. (2018). 483 SAFETY AND EFFICACY OF ENDOSCOPIC ULTRASOUND GUIDED RADIOFREQUENCY ABLATION (EUS-RFA) IN THE TREATMENT OF PANCREATIC LESIONS: A MULTI-CENTER EXPERIENCE. Gastrointestinal Endoscopy. 87(6). AB84–AB84. 18 indexed citations
7.
Raza, Ali, et al.. (2017). Uncommon Cause of Dysphagia in a Liver Transplant Recipient. Gastroenterology. 152(5). e3–e4.
8.
Raza, Ali, et al.. (2016). Rapid Infliximab Infusions Are Safe and Well Tolerated in Inflammatory Bowel Disease Patients. The American Journal of Gastroenterology. 111. S265–S265.
9.
Raza, Ali, et al.. (2013). Interferon‐associated retinopathy during the treatment of chronic hepatitis C: a systematic review. Journal of Viral Hepatitis. 20(9). 593–599. 20 indexed citations
10.
Díaz, Esperanza, Ali Raza, Hogne Sandvik, & Stefán Hjörleifsson. (2013). Immigrant and native regular general practitioners in Norway. A comparative registry-based observational study. European Journal of General Practice. 20(2). 93–99. 9 indexed citations
11.
Zafar, Muhammad Ahsan, Ali Raza, & Gaurav Khanna. (2013). Massive Subcutaneous Emphysema from a Complicated Intubation. Canadian Respiratory Journal. 20(4). 218–218. 2 indexed citations
12.
Malik, Rabia, et al.. (2008). Pakistani Urban Population Demonstrates a Poor Knowledge About Cancers: A Pilot Survey. Journal of Cancer Education. 23(4). 264–266. 8 indexed citations
13.
14.
Schwartz, Gregory G., Michael A. Bolognese, Richard Caplan, et al.. (2004). Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial. American Heart Journal. 148(1). 105–105. 45 indexed citations
15.
Blasetto, James W., Evan A. Stein, W. Virgil Brown, Rohini Chitra, & Ali Raza. (2003). Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. The American Journal of Cardiology. 91(5). 3–10. 125 indexed citations
16.
Martin, Paul, et al.. (2003). Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects. British Journal of Clinical Pharmacology. 55(1). 94–99. 77 indexed citations
17.
Martin, Paul, et al.. (2003). The effect of erythromycin on the pharmacokinetics of rosuvastatin. European Journal of Clinical Pharmacology. 59(1). 51–56. 77 indexed citations
18.
Olsson, Anders, Fergus McTaggart, & Ali Raza. (2002). Rosuvastatin: A Highly Effective New HMG‐CoA Reductase Inhibitor. Cardiovascular Drug Reviews. 20(4). 303–328. 174 indexed citations
19.
Olsson, Anders, et al.. (2001). Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. The American Journal of Cardiology. 88(5). 504–508. 175 indexed citations
20.
Paoletti, R., et al.. (2001). Rosuvastatin is more effective than pravastatin or simavastatin at improving the lipid profiles of hypercholesterolaemic patients. Atherosclerosis Supplements. 2(2). 87–87. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Pears Breakdown of academic impact, for papers by Mike J. Warwick Breakdown of academic impact, for papers by Aditi Sapre Breakdown of academic impact, for papers by Meehyung Cho Breakdown of academic impact, for papers by Bruce K. Birmingham Breakdown of academic impact, for papers by Julie Zalikowski Breakdown of academic impact, for papers by J.W. Nawrocki Breakdown of academic impact, for papers by André Árpád Faludi Breakdown of academic impact, for papers by Donald D. Cilla Breakdown of academic impact, for papers by James C. Stolzenbach
Rankless by CCL
2026